Alkermes plc. — Director's Dealing 2018

Feb 22, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Alkermes plc. (ALKS)
CIK: 0001520262
Period of Report: 2018-02-16

Reporting Person: Hopkinson Craig C. (SVP, Med Dev/Med Affairs, CMO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-02-16	Restricted Stock Unit Award	$0	A	13500	Acquired		Ordinary Shares (13500)	Direct
2018-02-16	Employee Stock Option (Right to Buy)	$67.26	A	54500	Acquired	2028-02-16	Ordinary Shares (54500)	Direct

Footnotes

F1: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/16/19.

F2: Shares subject to the stock option award vest in four equal annual installments commencing on 2/16/2019.